Laser-based therapies in the management of non-melanoma skin cancers: a narrative review
Lasers in Medical Science · 2026
DOI: 10.1007/s10103-026-04899-0 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Lasers in Medical Science, 2026. Verfasst von Francesco Russano und 10 weiteren Autor:innen. Beteiligte Einrichtung: Soft-Tissue, Peritoneum and Melanoma Surgical Oncology, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. Hauptthemen laut MEDLINE: Basal Cell Carcinoma, Carcinoma, Squamous Cell, Laser Therapy, Non-Melanoma Skin Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Padova.
Abstract (Originalsprache)
The rising global incidence of basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (cSCC) necessitates the exploration of tissue-sparing alternatives to surgical excision, which remains the gold standard. Laser systems (CO₂, Nd: YAG, PDL) offer a less invasive approach using selective photothermolysis, addressing functional and aesthetic concerns in anatomically sensitive areas. This narrative review summarizes the current clinical data on laser-based strategies for non-melanoma skin cancers (NMSC), focusing on treatment parameters, patient/lesion selection, oncologic outcomes (clearance and recurrence), and safety. A targeted search of PubMed, Embase, and Scopus up to May 2026 was synthesized narratively. For low-risk BCC, Nd: YAG lasers showed a 3.1% recurrence rate (7.9-year follow-up), while CO₂ lasers reported 9.4% (2.1-year follow-up). Pulsed dye laser (PDL) monotherapy was less reliable, with 38% recurrence. Evidence for cSCC remains limited, focusing on in situ disease and combined regimens. Integrating Reflectance Confocal Microscopy (RCM) and Laser-Assisted Drug Delivery (LADD) significantly improves oncologic efficacy and treatment depth. Laser therapy, particularly Nd: YAG and CO₂ systems, represents a viable tissue-sparing option primarily for low-risk BCC. However, evidence for cSCC remains limited and suggests higher recurrence rates, necessitating cautious patient selection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Soft-Tissue, Peritoneum and Melanoma Surgical Oncology, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
- Soft-Tissue, Peritoneum and Melanoma Surgical Oncology, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. luigi.dallolmo@unipd.it.
- Clinical Research Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. luigi.dallolmo@unipd.it.
- Clinical Research Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
- Immunology and Molecular Oncology Diagnostics Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
- Department of Surgery, Oncology and Gastroenterology (DISCOG), University of Padua, Padua, Italy.
Förderung
- Università degli Studi di Padova
Zitieren
APA
Russano, F., Brugnolo, D., Dall'Olmo, L., Callegarin, F., Del Fiore, P., Mazza, M., Camuccio, A., Scafuri, D., Furlan, D., Rastrelli, M., & Mocellin, S. (2026). Laser-based therapies in the management of non-melanoma skin cancers: a narrative review. Lasers in Medical Science. https://doi.org/10.1007/s10103-026-04899-0
Vancouver
Russano F, Brugnolo D, Dall'Olmo L, Callegarin F, Del Fiore P, Mazza M, et al. Laser-based therapies in the management of non-melanoma skin cancers: a narrative review. Lasers in Medical Science. 2026. doi:10.1007/s10103-026-04899-0
BibTeX
@article{Russano2026,
author = {Russano, Francesco and Brugnolo, Davide and Dall'Olmo, Luigi and Callegarin, Francesco and Del Fiore, Paolo and Mazza, Marcodomenico and Camuccio, Alberto and Scafuri, Daniele and Furlan, Davide and Rastrelli, Marco and Mocellin, Simone},
title = {Laser-based therapies in the management of non-melanoma skin cancers: a narrative review},
journal = {Lasers in Medical Science},
year = {2026},
doi = {10.1007/s10103-026-04899-0}
}
EUVIMED